Bisphenol A acts as an endocrine disrupting chemical, mimicking the action of the hormone estrogen in the body. Since hormones are effective at very low doses, the level of BPA exposure that can potentially cause damage is far lower than that of other types of toxic chemicals. Exposure to very small amounts of BPA can create a health risk, particularly in young children and unborn babies at certain stages of development.
A 2008 report of the National Toxicology Program of the Center for the Evaluation of Risks to Human Reproduction cited evidence that BPA exposure to fetuses, infants and children may alter the development of the brain and prostate gland.
Numerous studies have linked BPA to various diseases and conditions including breast cancer, prostate cancer, diabetes, heart disease, liver abnormalities and insulin resistance. it is also associated with reproductive disorders and early onset of puberty in girls. Evidence suggests that exposure to BPA in pregnancy may give rise to infertility and uterine dysfunction in female offspring.
While the U.S. Food and Drug Administration (FDA) has determined BPA to be safe, this assessment has been called into question by an independent advisory panel, which deemed the studies on which the FDA based their decision to be flawed due to unreliable and incomplete data. Currently, the FDA is carrying out research on the risks of BPA, and has taken steps to help decrease people's exposure to the chemical.